Uncover Cellular Heterogeneity with Advanced Single-cell Multi-Omics ApproachesWatch nowJoin us as we delve into the latest single cell sequencing technology advancements, offering deeper insights into complex biological systems. Our webinar will explore the expansion of applications beyond gene expression profiling, highlighting innovative multi-omic solutions aimed at providing a richer understanding of cellular events. From examining the transcriptome to profiling cell surface glycosylation, our experts will present transforming approaches in single cell sequencing.We’ll talk about: – Overview of single cell sequencing – Common bottlenecks in single cell sequencing – Getting started with single cell analysis – Singleron’s single cell solutions – Success stories of Singleron’s sequencing serviceCheck out our latests webinars Learn more Single Cell, Infinite Insights: Overcoming Obstacles for Top-Notch Data In this webinar, you will embark upon a research journey alongside Luigina De Leo and our other speakers, using a challenging case study focusing on… Read more Single-cell Multi-omics for Immuno-oncology - Prof. Fan Rong Prof. Fan Rong, the Harold Hodgkinson Professor of Biomedical Engineering and Pathology at Yale University, has been driving single-cell innovation since 2006. With expertise in… Read more Dissecting the tumor immune microenvironment and CAR-T cell therapy resistance - Dr. Maxine Lam Glioblastoma (GBM) remains one of the most lethal malignancies with limited treatment options and dismal prognoses. Immunotherapy, particularly chimeric antigen receptor (CAR)-T cell therapy, has… Read more
Single Cell, Infinite Insights: Overcoming Obstacles for Top-Notch Data In this webinar, you will embark upon a research journey alongside Luigina De Leo and our other speakers, using a challenging case study focusing on… Read more
Single-cell Multi-omics for Immuno-oncology - Prof. Fan Rong Prof. Fan Rong, the Harold Hodgkinson Professor of Biomedical Engineering and Pathology at Yale University, has been driving single-cell innovation since 2006. With expertise in… Read more
Dissecting the tumor immune microenvironment and CAR-T cell therapy resistance - Dr. Maxine Lam Glioblastoma (GBM) remains one of the most lethal malignancies with limited treatment options and dismal prognoses. Immunotherapy, particularly chimeric antigen receptor (CAR)-T cell therapy, has… Read more